October 29, 2024

Cigna Pathwell Specialty® is for patients using a specialty medication to treat a complex medical condition. As part of this in-network-only benefit plan option, certain […]

October 28, 2024

Beginning November 2, 2024, Evernorth® Behavioral Health (Evernorth), will adopt the use of The ASAM Criteria, 4th Edition to conduct substance use level of care […]

October 21, 2024

Evernorth® Behavioral Health (Evernorth) is committed to helping customers access behavioral care when they need it. To support these efforts, we have established standards regarding […]

October 18, 2024

Each year, Evernorth® Behavioral Health is required to evaluate its Behavioral Complex Case Management Program for accreditation purposes. Following are key findings from the 2023 […]

October 17, 2024

Effective for the 2025 plan year, Cigna HealthcareSM Medicare Advantage customer ID cards will no longer display the name and telephone number of the customer’s […]

October 16, 2024

Quality care is critical to protecting and improving the health and well-being of our customers. With the help of our behavioral health quality committee, Evernorth® […]

October 11, 2024

Beginning November 1, 2024, EviCore by Evernorth® will begin managing precertification for additional services for Cigna Healthcare℠ customers. These services include certain cardiac and vascular […]

October 11, 2024

Beginning November 1, 2024, EviCore by Evernorth® will begin managing precertification for certain Current Procedural Terminology (CPT®) codes for cardiac and vascular intervention procedures for […]

October 11, 2024

Beginning November 1, 2024, EviCore by Evernorth® will begin managing precertification for certain Current Procedural Terminology (CPT®) codes for spine surgeries and additional spine-related procedures […]

October 11, 2024

Beginning November 1, 2024, EviCore by Evernorth® will begin managing precertification for certain Current Procedural Terminology (CPT®) codes for molecular laboratory tests for Cigna Healthcare℠ […]

October 11, 2024

There is a temporary manufacturing shortage of the drug UDENYCA® (pegfilgrastim-cbqv). As a result, we have approved the use of NYVEPRIA™ as an alternative medication […]

October 11, 2024

The Provider Newsroom is easy to navigate. Valuable information relevant to your practice is readily available and easy to access through our Provider Newsroom, designed […]